{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:01:03Z","timestamp":1777604463999,"version":"3.51.4"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Aimwell Charitable Trust"},{"name":"Israel Ministry of Science and Technology"},{"name":"Harvard Medical School and Brigham and Women's Hospital"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.phrs.2020.104881","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T16:23:54Z","timestamp":1588609434000},"page":"104881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Granulocyte-targeted therapies for airway diseases"],"prefix":"10.1016","volume":"157","author":[{"given":"Luciana P.","family":"Tavares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Yong","family":"Peh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Shun Daniel","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadas","family":"Pahima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Maffia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterini","family":"Tiligada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Levi-Schaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.phrs.2020.104881_bib0005","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Collaborators, G.B.D.L.R.I","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"10100","key":"10.1016\/j.phrs.2020.104881_bib0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"390","author":"Collaborators, G.B.D.C.o.D","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.phrs.2020.104881_bib0015","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/all.13185","article-title":"Sputum basophils are increased in eosinophilic asthma compared with non-eosinophilic asthma phenotypes","volume":"72","author":"Brooks","year":"2017","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.phrs.2020.104881_bib0020","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/all.13480","article-title":"IL-3-producing basophils are required to exacerbate airway hyperresponsiveness in a murine inflammatory model","volume":"73","author":"Rignault-Bricard","year":"2018","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.phrs.2020.104881_bib0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00011-009-0042-6","article-title":"Mast cells and eosinophils: the two key effector cells in allergic inflammation","volume":"58","author":"Minai-Fleminger","year":"2009","journal-title":"Inflamm. Res."},{"issue":"9","key":"10.1016\/j.phrs.2020.104881_bib0030","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1172\/JCI85664","article-title":"Lung-resident eosinophils represent a distinct regulatory eosinophil subset","volume":"126","author":"Mesnil","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cell.2018.09.009","article-title":"Lung single-cell signaling interaction map reveals basophil role in macrophage imprinting","volume":"175","author":"Cohen","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0625.1999.tb00342.x","article-title":"Mast cells and their mediators in cutaneous wound healing--active participants or innocent bystanders?","volume":"8","author":"Artuc","year":"1999","journal-title":"Exp. Dermatol."},{"issue":"9","key":"10.1016\/j.phrs.2020.104881_bib0045","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nri1183","article-title":"Immune regulation by helminth parasites: cellular and molecular mechanisms","volume":"3","author":"Maizels","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2020.104881_bib0050","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1084\/jem.20181468","article-title":"Neutrophils instruct homeostatic and pathological states in naive tissues","volume":"215","author":"Casanova-Acebes","year":"2018","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0055","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.chom.2014.04.011","article-title":"The balancing act of neutrophils","volume":"15","author":"Bardoel","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.phrs.2020.104881_bib0060","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.it.2013.04.002","article-title":"Living and dying for inflammation: neutrophils, eosinophils, basophils","volume":"34","author":"Geering","year":"2013","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.stem.2010.02.013","article-title":"Distinguishing mast cell and granulocyte differentiation at the single-cell level","volume":"6","author":"Franco","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.phrs.2020.104881_bib0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008250","article-title":"Hematopoiesis","volume":"4","author":"Rieger","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"17","key":"10.1016\/j.phrs.2020.104881_bib0075","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/bloodadvances.2018019539","article-title":"Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells","volume":"2","author":"Grootens","year":"2018","journal-title":"Blood Adv."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2020.104881_bib0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2014.02.003","article-title":"Mast cell ontogeny: an historical overview","volume":"159","author":"Ribatti","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.phrs.2020.104881_bib0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-2095-2_6","article-title":"Systems approach to phagocyte production and activation: neutrophils and monocytes","volume":"844","author":"Mehta","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2020.104881_bib0090","doi-asserted-by":"crossref","first-page":"9095275","DOI":"10.1155\/2018\/9095275","article-title":"Eosinophils from physiology to disease: a comprehensive review","volume":"2018","author":"Ramirez","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"8","key":"10.1016\/j.phrs.2020.104881_bib0095","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/febs.13684","article-title":"Pulmonary resident neutrophils regulate the production of GM-CSF and alveolar macrophages","volume":"283","author":"Tian","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.phrs.2020.104881_bib0100","series-title":"Janeway\u2019s Immunobiology","author":"Weaver","year":"2017"},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1573398X10666141024220151","article-title":"Mast cells in lung homeostasis: beyond type I hypersensitivity","volume":"10","author":"Campillo-Navarro","year":"2014","journal-title":"Curr. Respir. Med. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/imr.12440","article-title":"Granulopoiesis and granules of human neutrophils","volume":"273","author":"Cowland","year":"2016","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00441-017-2748-z","article-title":"Neutrophils in the lung: \u201cthe first responders\u201d","volume":"371","author":"Aulakh","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"7","key":"10.1016\/j.phrs.2020.104881_bib0120","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines--chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.phrs.2020.104881_bib0125","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.4049\/jimmunol.181.11.8053","article-title":"Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases","volume":"181","author":"Hartl","year":"2008","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2020.104881_bib0130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/thoraxjnl-2018-212509","article-title":"Use of autologous (99m)Technetium-labelled neutrophils to quantify lung neutrophil clearance in COPD","volume":"74","author":"Tregay","year":"2019","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.phrs.2020.104881_bib0135","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1172\/JCI124616","article-title":"More friend than foe: the emerging role of neutrophils in tissue repair","volume":"129","author":"Peiseler","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.phrs.2020.104881_bib0140","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0145","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1152\/jappl.1987.62.3.1236","article-title":"Physiological neutrophil sequestration in the lung: visual evidence for localization in capillaries","volume":"62","author":"Lien","year":"1987","journal-title":"J Appl Physiol (1985)"},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0150","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1152\/jappl.1990.69.5.1767","article-title":"Retention of leukocytes in capillaries: role of cell size and deformability","volume":"69","author":"Downey","year":"1990","journal-title":"J Appl Physiol (1985)"},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0155","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1378\/chest.08-0422","article-title":"Advances in neutrophil biology: clinical implications","volume":"134","author":"Cowburn","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2020.104881_bib0160","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18411.1","article-title":"Understanding the role of neutrophils in chronic inflammatory airway disease","volume":"8","author":"Jasper","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.phrs.2020.104881_bib0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fcimb.2017.00160","article-title":"With friends like these: the complex role of neutrophils in the progression of severe pneumonia","volume":"7","author":"Pechous","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0170","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/ajrccm\/148.3.713","article-title":"Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?","volume":"148","author":"Sur","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \"N1\" versus \"N2\" TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/JLB.3MR1217-476R","article-title":"Contemporary understanding of the secretory granules in human eosinophils","volume":"104","author":"Melo","year":"2018","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0185","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4049\/jimmunol.1101795","article-title":"Cutting edge: histamine is required for IL-4-driven eosinophilic allergic responses","volume":"188","author":"Swartzendruber","year":"2012","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104881_bib0190","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jaci.2007.03.048","article-title":"Eosinophil trafficking in allergy and asthma","volume":"119","author":"Rosenberg","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"issue":"22","key":"10.1016\/j.phrs.2020.104881_bib0195","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM199805283382206","article-title":"Eosinophilia","volume":"338","author":"Rothenberg","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0200","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2007-01-071340","article-title":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus","volume":"110","author":"Phipps","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.phrs.2020.104881_bib0205","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.4049\/jimmunol.1600787","article-title":"Eosinophils promote antiviral immunity in mice infected with influenza a virus","volume":"198","author":"Samarasinghe","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri3341","article-title":"Eosinophils: changing perspectives in health and disease","volume":"13","author":"Rosenberg","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104881_bib0215","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/156652408785748013","article-title":"Targeting eosinophils in asthma","volume":"8","author":"Foster","year":"2008","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.phrs.2020.104881_bib0220","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.coi.2018.06.006","article-title":"Mast cells and basophils in allergic inflammation","volume":"54","author":"Kubo","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.phrs.2020.104881_bib0225","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2015.04.049","article-title":"Basophils in inflammation","volume":"778","author":"Schwartz","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0230","first-page":"148","article-title":"State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?","volume":"10","author":"Chirumbolo","year":"2012","journal-title":"Blood Transfus."},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0235","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/all.12072","article-title":"Basophils are recruited to inflamed lungs and exacerbate memory Th2 responses in mice and humans","volume":"68","author":"Wakahara","year":"2013","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri2458","article-title":"Newly discovered roles for basophils: a neglected minority gains new respect","volume":"9","author":"Karasuyama","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0245","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imr.12638","article-title":"Human eosinophils and mast cells: birds of a feather flock together","volume":"282","author":"Robida","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.phrs.2020.104881_bib0250","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-020-08779-5","article-title":"The role of mast cells in IgE-Independent lung diseases","author":"Komi","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.phrs.2020.104881_bib0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fimmu.2012.00238","article-title":"Novel identified receptors on mast cells","volume":"3","author":"Migalovich-Sheikhet","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2020.104881_bib0260","article-title":"Mast cell biology at molecular level: a comprehensive review","author":"Elieh Ali Komi","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.phrs.2020.104881_bib0265","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2014.00569","article-title":"Mast cell mediators: their differential release and the secretory pathways involved","volume":"5","author":"Moon","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0270","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imr.12636","article-title":"Is it time for a new classification of mast cells? What do we know about mast cell heterogeneity?","volume":"282","author":"Frossi","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.phrs.2020.104881_bib0275","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fncel.2019.00299","article-title":"Heterogeneity of human mast cells with respect to MRGPRX2 receptor expression and function","volume":"13","author":"Varricchi","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2222.1989.tb02357.x","article-title":"Mast cell heterogeneity","volume":"19","author":"Irani","year":"1989","journal-title":"Clin. Exp. Allergy"},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0285","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/cea.12675","article-title":"Mast cells in asthma--state of the art","volume":"46","author":"Bradding","year":"2016","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.phrs.2020.104881_bib0290","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.trsl.2016.01.005","article-title":"Mast cells and their activation in lung disease","volume":"174","author":"Virk","year":"2016","journal-title":"Transl. Res."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0295","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.4049\/jimmunol.1800648","article-title":"Hypercholesterolemia induces a mast Cell-CD4(+) t cell interaction in atherosclerosis","volume":"202","author":"Kritikou","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2020.104881_bib0300","series-title":"Asthma Fact Sheet","author":"Organization","year":"2017"},{"key":"10.1016\/j.phrs.2020.104881_bib0305","series-title":"Global Strategy for Asthma Management and Prevention","author":"Asthma","year":"2020"},{"issue":"10","key":"10.1016\/j.phrs.2020.104881_bib0310","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMra0804579","article-title":"Asthma","volume":"360","author":"Fanta","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0315","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0320","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat. Med."},{"issue":"9901","key":"10.1016\/j.phrs.2020.104881_bib0325","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0140-6736(13)61536-6","article-title":"Asthma","volume":"382","author":"Martinez","year":"2013","journal-title":"Lancet"},{"issue":"7203","key":"10.1016\/j.phrs.2020.104881_bib0330","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0335","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nri2275","article-title":"Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma","volume":"8","author":"Hammad","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0340","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJM200102013440507","article-title":"Advances in immunology - asthma","volume":"344","author":"Busse","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0345","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1067\/mai.2003.169","article-title":"The role of T lymphocytes in the pathogenesis of asthma","volume":"111","author":"Larch\u00e9","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9537","key":"10.1016\/j.phrs.2020.104881_bib0350","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(06)69290-8","article-title":"Asthma: defining of the persistent adult phenotypes","volume":"368","author":"Wenzel","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0355","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1034\/j.1600-065X.2001.790118.x","article-title":"IL-5-induced airway eosinophilia \u2013 the key to asthma?","volume":"179","author":"Hamelmann","year":"2001","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0360","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.183.1.195","article-title":"Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model","volume":"183","author":"Foster","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2020.104881_bib0365","series-title":"Asthma and COPD: Basic Mechanisms and Clinical Management","author":"Barnes","year":"2002"},{"issue":"6","key":"10.1016\/j.phrs.2020.104881_bib0370","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.coi.2007.07.021","article-title":"The role of eosinophils in airway tissue remodelling in asthma","volume":"19","author":"Kariyawasam","year":"2007","journal-title":"Curr. Opin. Immunol."},{"issue":"6760 Suppl","key":"10.1016\/j.phrs.2020.104881_bib0375","doi-asserted-by":"crossref","first-page":"B18","DOI":"10.1038\/35037014","article-title":"Induction and regulation of the IgE response","volume":"402","author":"Corry","year":"1999","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0380","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaci.2005.10.024","article-title":"IL-4\/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma","volume":"117","author":"Kabesch","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0385","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","article-title":"Mast cells and inflammation","volume":"1822","author":"Theoharides","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2020.104881_bib0390","doi-asserted-by":"crossref","first-page":"D1109","DOI":"10.2741\/krishnas","article-title":"The human mast cell: functions in physiology and disease","volume":"6","author":"Krishnaswamy","year":"2001","journal-title":"Front Biosci"},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0395","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-065X.2010.00922.x","article-title":"Targeting granulocyte apoptosis: mechanisms, models, and therapies","volume":"236","author":"Duffin","year":"2010","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0400","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.immuni.2009.08.008","article-title":"Biology of lung dendritic cells at the origin of asthma","volume":"31","author":"Lambrecht","year":"2009","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.phrs.2020.104881_bib0405","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nri914","article-title":"Regulation of mast-cell and basophil function and survival by IgE","volume":"2","author":"Kawakami","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0410","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1164\/ajrccm.160.5.9806170","article-title":"Neutrophilic inflammation in severe persistent asthma","volume":"160","author":"Jatakanon","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2020.104881_bib0415","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2222.2000.00092.x","article-title":"The role of eosinophils and neutrophils in inflammation","volume":"30","author":"Sampson","year":"2000","journal-title":"Clin. Exp. Allergy"},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0420","first-page":"340","article-title":"Neutrophils and asthma","volume":"19","author":"Monteseirin","year":"2009","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0425","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jaci.2009.02.024","article-title":"T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma","volume":"123","author":"Al-Ramli","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0430","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1165\/rcmb.2002-0166TR","article-title":"Matrix metalloproteinase-9 in lung remodeling","volume":"28","author":"Atkinson","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0435","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1165\/rcmb.2003-0008OC","article-title":"Accelerated airway dendritic cell maturation, trafficking, and elimination in a mouse model of asthma","volume":"29","author":"Vermaelen","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0440","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1165\/rcmb.2008-0028OC","article-title":"Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma","volume":"39","author":"Ito","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0445","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1378\/chest.06-2982","article-title":"LOss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils*","volume":"132","author":"Maneechotesuwan","year":"2007","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib0450","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","article-title":"Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial","volume":"68","author":"Brusselle","year":"2013","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.phrs.2020.104881_bib0455","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2213-2600(16)30227-2","article-title":"Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial","volume":"4","author":"O\u2019Byrne","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"11","key":"10.1016\/j.phrs.2020.104881_bib0460","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","article-title":"Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma","volume":"188","author":"Busse","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.phrs.2020.104881_bib0465","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S2213-2600(13)70128-0","article-title":"New treatments for severe treatment-resistant asthma: targeting the right patient","volume":"1","author":"Chung","year":"2013","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.phrs.2020.104881_bib0470","series-title":"Rang & Dale\u2019s Pharmacology","author":"Rang","year":"2007"},{"issue":"9743","key":"10.1016\/j.phrs.2020.104881_bib0475","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(10)61158-0","article-title":"Call for withdrawal of LABA single-therapy inhaler in asthma","volume":"376","author":"Beasley","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.phrs.2020.104881_bib0480","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/thorax.58.6.500","article-title":"Sustained reduction in bronchial hyperresponsiveness with inhaled fluticasone propionate within three days in mild asthma: time course after onset and cessation of treatment","volume":"58","author":"Sovij\u00e4rvi","year":"2003","journal-title":"Thorax"},{"issue":"4 Pt 1","key":"10.1016\/j.phrs.2020.104881_bib0485","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0091-6749(98)70268-4","article-title":"Efficacy of inhaled corticosteroids in asthma","volume":"102","author":"Barnes","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0490","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1542\/peds.2005-2842","article-title":"High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma","volume":"118","author":"Schuh","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0495","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaci.2011.11.006","article-title":"Severe asthma: advances in current management and future therapy","volume":"129","author":"Barnes","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2020.104881_bib0500","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/archinte.158.11.1213","article-title":"Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial","volume":"158","author":"Reiss","year":"1998","journal-title":"Arch. Intern. Med."},{"issue":"38","key":"10.1016\/j.phrs.2020.104881_bib0505","doi-asserted-by":"crossref","first-page":"32899","DOI":"10.1074\/jbc.R110.206466","article-title":"Biochemical basis of asthma therapy","volume":"286","author":"Barnes","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2020.104881_bib0510","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3389\/fphar.2017.00947","article-title":"Purinergic signaling in mast cell degranulation and asthma","volume":"8","author":"Gao","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104881_bib0515","article-title":"Francesca Levi-Schaffer","volume":"Vol. 1","author":"Ekaterini Tiligada","year":"2018"},{"issue":"10","key":"10.1016\/j.phrs.2020.104881_bib0520","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0525","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jaci.2013.11.026","article-title":"Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis","volume":"133","author":"Haldar","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0530","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1517\/14712598.2012.642359","article-title":"Benralizumab \u2013 a humanized mAb to IL-5R\u03b1 with enhanced antibody-dependent cell-mediated cytotoxicity \u2013 a novel approach for the treatment of asthma","volume":"12","author":"Ghazi","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"issue":"11","key":"10.1016\/j.phrs.2020.104881_bib0535","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2213-2600(14)70201-2","article-title":"Benralizumab, an anti-interleukin 5 receptor \u03b1 monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study","volume":"2","author":"Castro","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"10056","key":"10.1016\/j.phrs.2020.104881_bib0540","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0545","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4049\/jimmunol.169.2.1021","article-title":"Eosinophils express functional IL-13 in eosinophilic inflammatory diseases","volume":"169","author":"Schmid-Grendelmeier","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0550","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2015.05.008","article-title":"The differential expression of IL-4 and IL-13 and its impact on type-2 immunity","volume":"75","author":"Bao","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0555","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2249.2002.01973.x","article-title":"Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma","volume":"130","author":"Hart","year":"2002","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104881_bib0560","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.200909-1448OC","article-title":"A randomized, controlled, phase 2 study of AMG 317, an IL-4R\u03b1 antagonist, in patients with asthma","volume":"181","author":"Corren","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10039","key":"10.1016\/j.phrs.2020.104881_bib0565","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.phrs.2020.104881_bib0570","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.phrs.2020.104881_bib0575","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/thoraxjnl-2014-206719","article-title":"Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies","volume":"70","author":"Hanania","year":"2015","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.phrs.2020.104881_bib0580","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2213-2600(18)30184-X","article-title":"Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials","volume":"6","author":"Panettieri","year":"2018","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0585","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2018.05.029","article-title":"Treatment of atopic dermatitis with tralokinumab, an anti\u2013IL-13 mAb","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0590","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccm.2012.06.006","article-title":"Resolution of inflammation in asthma","volume":"33","author":"Levy","year":"2012","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.phrs.2020.104881_bib0595","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-physiol-021113-170408","article-title":"Resolution of acute inflammation in the lung","volume":"76","author":"Levy","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phrs.2020.104881_bib0600","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mam.2017.04.003","article-title":"Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation","volume":"58","author":"Duvall","year":"2017","journal-title":"Mol. Aspects Med."},{"issue":"6","key":"10.1016\/j.phrs.2020.104881_bib0605","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1164\/rccm.200801-061OC","article-title":"Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma","volume":"178","author":"Planaguma","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib0610","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/mi.2014.116","article-title":"Lipoxin B(4) promotes the resolution of allergic inflammation in the upper and lower airways of mice","volume":"8","author":"Karra","year":"2015","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0615","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2019.09.028","article-title":"Cysteinyl maresins regulate the prophlogistic lung actions of cysteinyl leukotrienes","volume":"145","author":"Levy","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib0620","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/15412555.2018.1476475","article-title":"Neutrophilic inflammation in the pathogenesis of chronic obstructive pulmonary disease","volume":"15","author":"Butler","year":"2018","journal-title":"Copd"},{"key":"10.1016\/j.phrs.2020.104881_bib0625","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/gheg.2018.1","article-title":"The unmet global burden of COPD","volume":"3","author":"Quaderi","year":"2018","journal-title":"Glob Health Epidemiol Genom"},{"key":"10.1016\/j.phrs.2020.104881_bib0630","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3389\/fphar.2017.00512","article-title":"Role of proteases in chronic obstructive pulmonary disease","volume":"8","author":"Pandey","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"13","key":"10.1016\/j.phrs.2020.104881_bib0635","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1042\/CS20160487","article-title":"Cellular and molecular mechanisms of asthma and COPD","volume":"131","author":"Barnes","year":"2017","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0640","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12931-018-0883-z","article-title":"Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases","volume":"19","author":"Crisford","year":"2018","journal-title":"Respir. Res."},{"issue":"9","key":"10.1016\/j.phrs.2020.104881_bib0645","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7090244","article-title":"Proteases and their inhibitors in chronic obstructive pulmonary disease","volume":"7","author":"Dey","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.phrs.2020.104881_bib0650","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.2147\/COPD.S176122","article-title":"Role of inflammatory cells in airway remodeling in COPD","volume":"13","author":"Wang","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.phrs.2020.104881_bib0655","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50990","article-title":"Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation","volume":"8","author":"Rahman","year":"2019","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib0660","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1042\/CS20180912","article-title":"Matrine reduces cigarette smoke-induced airway neutrophilic inflammation by enhancing neutrophil apoptosis","volume":"133","author":"Yu","year":"2019","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0665","doi-asserted-by":"crossref","first-page":"e0210188","DOI":"10.1371\/journal.pone.0210188","article-title":"In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist \/beta2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients","volume":"14","author":"Milara","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib0670","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00970-2017","article-title":"Neutrophil extracellular trap formation is regulated by CXCR2 in COPD neutrophils","volume":"51","author":"Pedersen","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.phrs.2020.104881_bib0675","doi-asserted-by":"crossref","first-page":"e0180742","DOI":"10.1371\/journal.pone.0180742","article-title":"Protective effect of Galectin-9 in murine model of lung emphysema: involvement of neutrophil migration and MMP-9 production","volume":"12","author":"Horio","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.phrs.2020.104881_bib0680","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1042\/CS20180057","article-title":"The neutrophil-mobilizing cytokine interleukin-26 in the airways of long-term tobacco smokers","volume":"132","author":"Che","year":"2018","journal-title":"Clin. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2020.104881_bib0685","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/cpt.1053","article-title":"Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, exposure-dependent reduction in neutrophil elastase activity in healthy subjects","volume":"104","author":"Palmer","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"13","key":"10.1016\/j.phrs.2020.104881_bib0690","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/cvr\/cvy219","article-title":"From design to the clinic: practical guidelines for translating cardiovascular nanomedicine","volume":"114","author":"Cicha","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.phrs.2020.104881_bib0695","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.nano.2016.06.008","article-title":"Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases","volume":"12","author":"Vij","year":"2016","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.phrs.2020.104881_bib0700","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.chest.2017.05.019","article-title":"New anti-eosinophil drugs for asthma and COPD: targeting the trait!","volume":"152","author":"Bel","year":"2017","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.phrs.2020.104881_bib0705","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","article-title":"Eosinophils in COPD: just another biomarker?","volume":"5","author":"Bafadhel","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.phrs.2020.104881_bib0710","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40264-017-0522-5","article-title":"Targeting Interleukin-5 or Interleukin-5Ralpha: safety considerations","volume":"40","author":"Bagnasco","year":"2017","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0715","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12931-018-0968-8","article-title":"Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases","volume":"20","author":"Sridhar","year":"2019","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0720","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12931-018-0751-x","article-title":"A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial","volume":"19","author":"Greulich","year":"2018","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0725","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.chest.2016.06.009","article-title":"New developments in mast cell biology: clinical implications","volume":"150","author":"Arthur","year":"2016","journal-title":"Chest"},{"issue":"51","key":"10.1016\/j.phrs.2020.104881_bib0730","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1073\/pnas.1813927115","article-title":"Basophils trigger emphysema development in a murine model of COPD through IL-4-mediated generation of MMP-12-producing macrophages","volume":"115","author":"Shibata","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.phrs.2020.104881_bib0735","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/14656566.2017.1328497","article-title":"An update on the pharmacotherapeutic management of lower respiratory tract infections","volume":"18","author":"Cazzola","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"issue":"137","key":"10.1016\/j.phrs.2020.104881_bib0740","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/16000617.0034-2015","article-title":"Therapeutic strategies in pneumonia: going beyond antibiotics","volume":"24","author":"Muller-Redetzky","year":"2015","journal-title":"Eur. Respir. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2020.104881_bib0745","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/rccm.200909-1427SO","article-title":"Innate immune recognition in infectious and noninfectious diseases of the lung","volume":"181","author":"Opitz","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.phrs.2020.104881_bib0750","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1182\/blood-2003-04-1078","article-title":"Toll-like receptors stimulate human neutrophil function","volume":"102","author":"Hayashi","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib0755","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12098-016-2040-3","article-title":"Chronic granulomatous disease","volume":"83","author":"Rawat","year":"2016","journal-title":"Indian J. Pediatr."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0760","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.currproblcancer.2015.08.001","article-title":"Infectious thoracic disease in patients with neutropenia","volume":"39","author":"Turner","year":"2015","journal-title":"Curr. Probl. Cancer"},{"issue":"6252","key":"10.1016\/j.phrs.2020.104881_bib0765","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa4352","article-title":"Neutrophil trails guide influenza-specific CD8(+) T cells in the airways","volume":"349","author":"Lim","year":"2015","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.phrs.2020.104881_bib0770","doi-asserted-by":"crossref","first-page":"e1005126","DOI":"10.1371\/journal.ppat.1005126","article-title":"Extracellular adenosine protects against Streptococcus pneumoniae lung infection by regulating pulmonary neutrophil recruitment","volume":"11","author":"Bou Ghanem","year":"2015","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0775","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2013.06.013","article-title":"A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection","volume":"154","author":"Brandes","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0780","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1038\/s41467-019-11249-y","article-title":"Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection","volume":"10","author":"Tang","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.phrs.2020.104881_bib0785","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/adc.88.10.922","article-title":"Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis","volume":"88","author":"McNamara","year":"2003","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0790","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1442-200x.2005.02039.x","article-title":"Neutrophil-mediated inflammation in respiratory syncytial viral bronchiolitis","volume":"47","author":"Yasui","year":"2005","journal-title":"Pediatr. Int."},{"issue":"11","key":"10.1016\/j.phrs.2020.104881_bib0795","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.4049\/jimmunol.0902497","article-title":"Neutrophils ameliorate lung injury and the development of severe disease during influenza infection","volume":"183","author":"Tate","year":"2009","journal-title":"J. Immunol."},{"issue":"Pt 3","key":"10.1016\/j.phrs.2020.104881_bib0800","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1099\/vir.0.061986-0","article-title":"Neutrophils are needed for an effective immune response against pulmonary rat coronavirus infection, but also contribute to pathology","volume":"95","author":"Haick","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.phrs.2020.104881_bib0805","article-title":"Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage","author":"Jingyuan Liu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.phrs.2020.104881_bib0810","article-title":"Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China","author":"Li","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.phrs.2020.104881_bib0815","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: the perspectives on immune responses","author":"Shi","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.phrs.2020.104881_bib0820","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fimmu.2017.00550","article-title":"A role for neutrophils in viral respiratory disease","volume":"8","author":"Camp","year":"2017","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.phrs.2020.104881_bib0825","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0830","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01397-16","article-title":"Klebsiella pneumoniae siderophores induce inflammation, bacterial dissemination, and HIF-1alpha stabilization during pneumonia","volume":"7","author":"Holden","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.phrs.2020.104881_bib0835","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3389\/fimmu.2018.02275","article-title":"Role of inflammatory risk factors in the pathogenesis of Streptococcus pneumoniae","volume":"9","author":"Sohail","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2020.104881_bib0840","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fpubh.2013.00019","article-title":"Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells","volume":"1","author":"Pott","year":"2013","journal-title":"Front. Public Health"},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib0845","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00011-016-0996-0","article-title":"The inflammatory response triggered by Influenza virus: a two edged sword","volume":"66","author":"Tavares","year":"2017","journal-title":"Inflamm. Res."},{"issue":"12","key":"10.1016\/j.phrs.2020.104881_bib0850","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1164\/rccm.200402-200OC","article-title":"Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection","volume":"170","author":"Tsai","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2020.104881_bib0855","doi-asserted-by":"crossref","first-page":"649570","DOI":"10.1155\/2012\/649570","article-title":"Macrolide therapy in respiratory viral infections","volume":"2012","author":"Min","year":"2012","journal-title":"Mediators Inflamm."},{"issue":"9","key":"10.1016\/j.phrs.2020.104881_bib0860","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/14787210.2018.1512403","article-title":"Severe community-acquired pneumonia: current management and future therapeutic alternatives","volume":"16","author":"Garnacho-Montero","year":"2018","journal-title":"Expert Rev. Anti. Ther."},{"issue":"12","key":"10.1016\/j.phrs.2020.104881_bib0865","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0870","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00764-17","article-title":"Treatment with atorvastatin provides additional benefits to imipenem in a model of gram-negative pneumonia induced by Klebsiella pneumoniae in mice","volume":"62","author":"de Paula","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.phrs.2020.104881_bib0875","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s10096-019-03684-y","article-title":"Statins and outcomes of hospitalized patients with laboratory-confirmed 2017\u20132018 influenza","volume":"38","author":"Atamna","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.phrs.2020.104881_bib0880","doi-asserted-by":"crossref","first-page":"d1642","DOI":"10.1136\/bmj.d1642","article-title":"Effect of statin treatment on short term mortality after pneumonia episode: cohort study","volume":"342","author":"Douglas","year":"2011","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.phrs.2020.104881_bib0885","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/cid\/cis733","article-title":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes","volume":"55","author":"Mortensen","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib0890","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/cc11418","article-title":"The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study","volume":"16","author":"Nielsen","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.phrs.2020.104881_bib0895","doi-asserted-by":"crossref","first-page":"b2137","DOI":"10.1136\/bmj.b2137","article-title":"Statin use and risk of community acquired pneumonia in older people: population based case-control study","volume":"338","author":"Dublin","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2020.104881_bib0900","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2180-12-73","article-title":"Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia","volume":"12","author":"Boyd","year":"2012","journal-title":"BMC Microbiol."},{"issue":"10","key":"10.1016\/j.phrs.2020.104881_bib0905","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1164\/rccm.201812-2328OC","article-title":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial","volume":"200","author":"Sapey","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.phrs.2020.104881_bib0910","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00003072-200412000-00008","article-title":"Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy","volume":"29","author":"Trieu","year":"2004","journal-title":"Clin. Nucl. Med."},{"issue":"9977","key":"10.1016\/j.phrs.2020.104881_bib0915","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib0920","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.21037\/jtd.2016.02.43","article-title":"Corticosteroids in the adjunctive therapy of community-acquired pneumonia: an appraisal of recent meta-analyses of clinical trials","volume":"8","author":"Feldman","year":"2016","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0925","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1183\/09031936.00027607","article-title":"Effects of systemic steroids in patients with severe community-acquired pneumonia","volume":"30","author":"Garcia-Vidal","year":"2007","journal-title":"Eur. Respir. J."},{"issue":"13","key":"10.1016\/j.phrs.2020.104881_bib0930","doi-asserted-by":"crossref","first-page":"e14636","DOI":"10.1097\/MD.0000000000014636","article-title":"Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: a systematic review and meta-analysis","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.phrs.2020.104881_bib0935","first-page":"CD007720","article-title":"Corticosteroids for pneumonia","volume":"12","author":"Stern","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2020.104881_bib0940","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19124090","article-title":"How glucocorticoids affect the neutrophil life","volume":"19","author":"Ronchetti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.104881_bib0945","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40360-015-0017-x","article-title":"The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects","volume":"16","author":"Miller","year":"2015","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"7","key":"10.1016\/j.phrs.2020.104881_bib0950","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2222.2012.04014.x","article-title":"Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial","volume":"42","author":"Nair","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.phrs.2020.104881_bib0955","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3389\/fimmu.2017.01799","article-title":"CXCR1\/2 antagonism is protective during influenza and post-influenza pneumococcal infection","volume":"8","author":"Tavares","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib0960","doi-asserted-by":"crossref","first-page":"ofz106","DOI":"10.1093\/ofid\/ofz106","article-title":"Therapeutically attenuating neutrophil recruitment with a CXCR2 antagonist in combination with oseltamivir ameliorates influenza-induced lung injury and disease","volume":"6","author":"Washburn","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.phrs.2020.104881_bib0965","series-title":"Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza","author":"GlaxoSmithKline","year":"2016"},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0970","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ajpath.2011.03.013","article-title":"Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis","volume":"179","author":"Narasaraju","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0975","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.chest.2017.03.056","article-title":"The role of neutrophil elastase inhibitors in lung diseases","volume":"152","author":"Polverino","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib0980","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib0985","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/mi.2015.129","article-title":"Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation","volume":"9","author":"Abdulnour","year":"2016","journal-title":"Mucosal Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2020.104881_bib0990","doi-asserted-by":"crossref","first-page":"12188","DOI":"10.1096\/fj.201901265R","article-title":"The annexin A1\/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model","volume":"33","author":"Schloer","year":"2019","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib0995","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1096\/fj.201902172R","article-title":"The Annexin A1\/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia","volume":"34","author":"Machado","year":"2020","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.phrs.2020.104881_bib1000","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.4049\/jimmunol.1602090","article-title":"15-epi-Lipoxin A4, resolvin D2, and resolvin D3 induce NF-kappaB regulators in bacterial pneumonia","volume":"200","author":"Sham","year":"2018","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib1005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/mi.2009.141","article-title":"Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4","volume":"3","author":"Planaguma","year":"2010","journal-title":"Mucosal Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib1010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood-2013-05-502443","article-title":"Activated mouse eosinophils protect against lethal respiratory virus infection","volume":"123","author":"Percopo","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib1015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1165\/rcmb.2015-0405OC","article-title":"Human and mouse eosinophils have antiviral activity against parainfluenza virus","volume":"55","author":"Drake","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib1020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.4049\/jimmunol.160.3.1279","article-title":"Eosinophils bind rhinovirus and activate virus-specific T cells","volume":"160","author":"Handzel","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2020.104881_bib1025","article-title":"Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression","author":"Liu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib1030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1189\/jlb.70.5.691","article-title":"Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens","volume":"70","author":"Rosenberg","year":"2001","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib1035","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/JVI.01536-14","article-title":"Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease","volume":"89","author":"Su","year":"2015","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib1040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood.V52.3.609.609","article-title":"Comparison of intracellular bactericidal activities of human neutrophils and eosinophils","volume":"52","author":"DeChatelet","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2020.104881_bib1045","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.3389\/fimmu.2018.02763","article-title":"Eosinophil extracellular traps and inflammatory pathologies-untangling the web!","volume":"9","author":"Mukherjee","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104881_bib1050","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jpeds.2009.12.001","article-title":"A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation","volume":"156","author":"Kim","year":"2010","journal-title":"J. Pediatr."},{"issue":"9","key":"10.1016\/j.phrs.2020.104881_bib1055","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/all.12662","article-title":"Basophils exhibit antibacterial activity through extracellular trap formation","volume":"70","author":"Yousefi","year":"2015","journal-title":"Allergy"},{"issue":"29","key":"10.1016\/j.phrs.2020.104881_bib1060","doi-asserted-by":"crossref","first-page":"20809","DOI":"10.1074\/jbc.M611842200","article-title":"The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections","volume":"282","author":"Thakurdas","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.phrs.2020.104881_bib1065","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.4049\/jimmunol.0900802","article-title":"Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin","volume":"184","author":"Cruse","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104881_bib1070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaci.2004.03.049","article-title":"Activation of mast cells by double-stranded RNA: evidence for activation through toll-like receptor 3","volume":"114","author":"Kulka","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2020.104881_bib1075","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.1202096","article-title":"Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling","volume":"190","author":"Graham","year":"2013","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib1080","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0032-2016","article-title":"Paul Ehrlich and the early history of granulocytes","volume":"4","author":"Kay","year":"2016","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"10.1016\/j.phrs.2020.104881_bib1085","first-page":"94","article-title":"To use or not to use corticosteroids for pneumonia? A clinician\u2019s perspective","volume":"77","author":"Confalonieri","year":"2012","journal-title":"Monaldi Arch. Chest Dis."},{"issue":"4","key":"10.1016\/j.phrs.2020.104881_bib1090","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1164\/ajrccm.160.4.9901075","article-title":"Corticosteroids in acute respiratory failure","volume":"160","author":"Jantz","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9782","key":"10.1016\/j.phrs.2020.104881_bib1095","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Meijvis","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2020.104881_bib1100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study","volume":"171","author":"Confalonieri","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820311890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820311890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:10:47Z","timestamp":1760911847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820311890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":220,"alternative-id":["S1043661820311890"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104881","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granulocyte-targeted therapies for airway diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104881"}}